Cancer of the breast without ER, PR, HER2 expression, 48 cases (1.5mm), set 1 |
BRC964 |
Pantomics |
1 |
EUR 492 |
Description: Breast cancer tissue array without expressions of ER, PR, HER2 (triple negative), set 1, 96 cores, 48 cases containing at least five control cases with various levels of ER, PR, HER2, and 43 cases with no detectable expressions of these three markers. Since all the triple negative cases were selected out based on TMA screening, the IHC results only reflect the phenotypic status of individual cores tested at certain cutting level. We can not exclude the possibility that, at a late cutting level, a small fraction of the cores may be positive for one or more of these three markers. |
Breast Elisa Laboratories manufactures the elisa for the detention of er and pr in breast cancer reagents distributed by Genprice. The Elisa For The Detention Of Er And Pr In Breast Cancer reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact breast elisa. Other Elisa products are available in stock. Specificity: Elisa Category: For Group: The Detention
Breast cancer tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR and Her-2), 104 cases/208 cores |
BioCoreUSA |
row: 13; column: 16; cores: 208; cases: 104 |
EUR 474 |
Description: Breast carcinoma tissue microarray, containing 95 cases of invasive carcinoma of no special type, 2 mixed carcinoma, 3 mucinous carcinoma, 1 each of invasive lobular carcinoma, papillary mucinous adenocarcinoma, squamous cell carcinom and intraductal carcinoma, duplicate cores per case |
Advanced stage breast cancer and normal breast tissue array |
TissueArray |
each |
EUR 306 |
Description: Advanced stage breast cancer and normal breast tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), ER\PR\HER-2\Ki-67 marker, 119 cases/119 cores, (1.5mm) |
Breast Tumor Tissue Array - Duplicated 36 cases covering all the common types of breast cancer and 12 cases of normal an |
Biochain |
5 slides |
EUR 1657.2 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
Breast Tumor Tissue Array - Duplicated 36 cases covering all the common types of breast cancer and 12 cases of normal an |
Biochain |
5 slides |
EUR 1657.2 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
Cancer of the breast, 75 cases (1.1mm), set 1 |
Pantomics |
1 |
EUR 300 |
Description: Breast cancer tissue array, set 1, non-overlapping with BRC1502 to BRC15011,150 cores from normal/benign (5 cases) and cancer (70 cases) tissues in duplicates with grading, TNM staging, and AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data. |
Cancer of the breast, 75 cases (1.1mm), set 10 |
Pantomics |
1 |
EUR 300 |
Description: Breast cancer tissue array, set 10, non-overlapping with BRC1501 to BRC1509 or BRC15011 to BRC15011 or BRC1503,150 cores from normal/benign (5 cases) and cancer (70 cases) tissues in duplicates with grading, TNM staging data, AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data. |
Cancer of the breast, 75 cases (1.1mm), set 11 |
Pantomics |
1 |
EUR 300 |
Description: Breast cancer tissue array, set 11, non-overlapping with BRC1501 to BRC15010,150 cores from normal/benign (5 cases) and cancer (70 cases) tissues in duplicates with grading, TNM staging data, AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data. |
The Detention information
Human tumor marker CA549 for breast cancer ELISA Kit |
SL3271Hu |
Sunlong |
96 Tests |
EUR 468 |
|
Breast Tumor Tissue Array - Duplicated 36 cases covering all the common types of breast cancer and 12 cases of normal an |
Z7020008 |
Biochain |
5 slides |
EUR 1657.2 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
Breast Tumor Tissue Array - Duplicated 36 cases covering all the common types of breast cancer and 12 cases of normal an |
Z7020009 |
Biochain |
5 slides |
EUR 1657.2 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
ELISA Kit for Breast Cancer Susceptibility Protein 2 (BRCA2) |
SEB364Hu |
Cloud-Clone |
96Т |
EUR 665 |
|
ELISA Kit for Breast Cancer Susceptibility Protein 2 (BRCA2) |
SEB364Mu |
Cloud-Clone |
96Т |
EUR 684 |
|
ELISA Kit for Breast Cancer Susceptibility Protein 1 (BRCA1) |
SEB376Hu |
Cloud-Clone |
96Т |
EUR 665 |
|
Breast cancer and normal tissue array |
BR8014 |
TissueArray |
each |
EUR 306 |
Description: Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases/80 cores, replaced by BR8015 |
Cancer of the breast, 75 cases (1.1mm), set 13HumanBreastBreastMalignant |
BRC15013 |
Pantomics |
1.1mm |
EUR 289 |
BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) APC |
MBS6135498-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) APC |
MBS6135498-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (AP) |
MBS6130195-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (AP) |
MBS6130195-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
BCAS1, CT (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) |
MBS646867-005mg |
MyBiosource |
0.05mg |
EUR 875 |
BCAS1, CT (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) |
MBS646867-5x005mg |
MyBiosource |
5x0.05mg |
EUR 3780 |
BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (HRP) |
MBS6151407-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (HRP) |
MBS6151407-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (PE) |
MBS6156710-01mL |
MyBiosource |
0.1(mL |
EUR 875 |